Drug Pipeline

Platinum chemotherapy (cisplatin or carboplatin) Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
4
Active Studies
1
Recruiting
1
Phase 3
4
Top Sponsors
4
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-06-03 NCT06917079
BBO-11818 in Adult Subjects With KRAS Mutant Cancer		 Primary endpoint(s) modified
2026-06-03 NCT06917079
BBO-11818 in Adult Subjects With KRAS Mutant Cancer		 Enrollment increased: 387 -> 665 participants
2026-06-03 NCT06917079
BBO-11818 in Adult Subjects With KRAS Mutant Cancer		 Trial arms changed: 14 -> 20
2026-06-03 NCT06917079
BBO-11818 in Adult Subjects With KRAS Mutant Cancer		 Trial sites expanded: 11 -> 17 locations
Active Studies by Phase
Phase 3
1
Phase 2
2
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07524257 Phase 3 Study of Nogapendekin Alfa Inbakicept Plus Standard of Care vs Standard of Care… NSCLC (Advanced Non-small Cell Lung Cancer) Not Yet Recruiting
Phase 2
NCT07005336 A Study to Compare Uliledlimab Combined With Sintilimab and Chemotherapy Versus… Non Small Cell Lung Cancer Active, Not Recruiting
NCT07538258 Benmelstobart Plus Anlotinib, Chemotherapy and Thoracic Radiation for Limited-Stage Small… Limited-stage Small Cell Lung Cancer (LS-SCLC) Not Yet Recruiting
Phase 1
NCT06917079 BBO-11818 in Adult Subjects With KRAS Mutant Cancer Non-Small Cell Lung Cancer Recruiting
Sponsors Running Platinum chemotherapy (cisplatin or carboplatin) Trials
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics) (1) TJ Biopharma Co., Ltd. (1) ImmunityBio, Inc. (1) Yayi He (1)
Disease Areas
Lung Cancer (4) Non-Small Cell Lung Cancer (NSCLC) (3) Colorectal Cancer (1) Pancreatic Cancer (1) Small Cell Lung Cancer (1)
Get alerts when Platinum chemotherapy (cisplatin or carboplatin) trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free